At a glance
- Originator Abbott Laboratories
- Class Anti-inflammatories; Piperazines
- Mechanism of Action Intercellular adhesion molecule 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 30 Jun 2003 Discontinued - Preclinical for Inflammation in USA (unspecified route)
- 18 Sep 2000 New profile
- 18 Sep 2000 Preclinical development for Inflammation in USA (Unknown route)